Safflower (Carthamus tinctorius)

Nomenclature & Taxonomic Classification

Physical Description: * Growth Habit: Annual, thistle-like herbaceous plant.
- Morphology: Erect, branching stems reaching 30–150 cm in height. Leaves are alternate, oblong, and spine-toothed. Branch tips bear globular flower heads (capitula) with brilliant yellow, orange, or deep red tubular florets.
Habitat & Cultivation: Native to parts of Asia and the Mediterranean basin. Thrives in arid and semi-arid environments with deep, well-drained soils and high solar exposure.
Sustainability Status: Secure; widely cultivated globally as an oilseed and dye crop.

Western Tissue States: Corrects Cold/Stagnation (invigorates blood, breaks up pelvic and peripheral congestion).
Traditional Vector:
- Ayurveda: Rasa (Taste): Tikta (Bitter), Katu (Pungent) | Virya (Energy): Ushna (Heating) | Vipaka (Post-Digestive Effect): Katu | Dosha Modulation: Increases Pitta; reduces Vata and Kapha in moderation.
- Traditional Chinese Medicine: Temperature: Warm | Taste: Pungent | Organ Meridians Entered: Heart, Liver.
Historical Folk Use: Extensively used in Traditional Chinese Medicine (Hong Hua) to invigorate blood, harmonize menses, dispel blood stasis, and alleviate the pain of traumatic injuries.

Primary Phytochemicals: Chalcone C-glycosides (carthamin, hydroxysafflor yellow A), flavonoids (quercetin, rutin), and fixed oils (linoleic and oleic acids in the seeds).
Mechanism of Action: > Hydroxysafflor yellow A (HSYA) acts as a potent antagonist to platelet-activating factor (PAF) receptors, thereby inhibiting platelet aggregation and reducing blood viscosity. It downregulates inflammatory cascades by suppressing NF-κB activation, protecting vascular endothelial cells from oxidative stress and improving microcirculation.

Primary Indications: Functional amenorrhea, dysmenorrhea with dark clotting, ecchymosis (bruising), and localized pain or swelling secondary to trauma or stasis.
Secondary Indications: Mild hypercholesterolemia, coronary microvascular dysfunction, and early-stage peripheral vascular disease.
Modern Clinical Evidence: Human clinical trials in cardiology and gynecology demonstrate that safflower extracts effectively improve blood rheology, decrease plasma viscosity, and reduce pelvic pain markers associated with stagnation patterns.

Optimal Menstruum & Extraction Guidelines: Water-soluble pigments (hydroxysafflor yellow A) extract easily in hot aqueous infusions. Alcohol-soluble components require a lower-to-mid range hydroethanolic menstruum (40–50% EtOH) to achieve full-spectrum therapeutic profiles.

Delivery Method	Standard Clinical Dosage	Frequency / Administration
Crude Herb Powder	3–9 grams	Daily, mixed in warm water or decoction
Infusion	1–2 tsp of dried florets per cup	Steeped covered 10–15 mins, 2–3x daily
Tincture (1:5)	2–4 mL	Three times daily in warm water
Fluid Extract (1:1)	1–2 mL	Twice daily

Contraindications: Strictly contraindicated during pregnancy due to its potent blood-invigorating, emmenagogue, and potential uterine-stimulating properties (risk of miscarriage). Contraindicated in patients with active bleeding disorders or hemorrhagic diathesis.
Side Effects & Toxicity Thresholds: Generally safe within standard parameters; excessive dosing may cause menorrhagia or gastrointestinal discomfort.
Pharmaceutical Cross-Interactions: * Enzyme Alterations: Mild, non-significant modulation of CYP450 pathways.
- Additive Pathways: Exerts strong additive effects with anticoagulant and antiplatelet drugs (e.g., Warfarin, Aspirin, Clopidogrel), significantly elevating bleeding risks.

Pharmacopoeia of the People’s Republic of China (Da Huang & Hong Hua protocols).
Bensky, D., & Gamble, A. Chinese Herbal Medicine: Materia Medica.
Zang, B. X., et al. (2002). “Effects of Hydroxysafflor Yellow A on platelet aggregation.” Journal of Asian Natural Products Research.